CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
Povidone-Iodinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00386958
NCT00386958Phase 2Completed
CompareCT.gov

A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center·interventional·Posted Oct 12, 2006·Updated Aug 23, 2016

In Brief

A Phase 2 clinical trial evaluating Povidone-Iodine for Infected Corneal Ulcers and 3 related conditions. Completed, across 1 site.

Detailed Summary

Bacterial corneal ulcers are a leading cause of pediatric blindness in underdeveloped countries due to a lack of antibiotic availability and affordability, among other reasons. Povidone-iodine, an inexpensive and readily available broad-spectrum antimicrobial agent, may be an effective and affordable treatment for corneal ulcers, allowing preservation of sight for those afflicted with this disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfected Corneal Ulcers, Bacterial Keratitis, Corneal Ulcer, Childhood Blindness
CountriesUnited States
CollaboratorsThrasher Research Fund, Research to Prevent Blindness, University of California, Los Angeles, Kolokotrones Family Foundation, University of the Philippines, L.V. Prasad Eye Institute, Joseph Eye Hospital

Timeline

Phase 2CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 12, 2006
Enrollment StartNov 1, 2002
Primary CompletionJan 1, 2006
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 19.7 years ago

Interventions

Povidone-Iodinedrug